Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$182,793
in 3 filings

Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-12-04 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units (RSUs) −1,042 4,167
2019-11-21 Barrett Elizabeth A. Chief Executive Officer Purchase +7,530 $28.00 $211K 16,548
2019-11-20 Barrett Elizabeth A. Chief Executive Officer Purchase +7,470 $28.00 $209K 9,018
2019-11-20 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion +1,042 3,793
2019-11-20 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −354 $28.41 $10K 3,439
2019-11-20 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −1,042 7,291
2019-11-19 Schoenberg Mark Chief Medical Officer Purchase +1,960 $28.17 $55K 7,967
2019-11-15 Barrett Elizabeth A. Chief Executive Officer Purchase +1,548 $26.00 $40K 1,548
2019-11-14 Mullennix Stephen Chief Operating Officer Exercise or conversion +1,759 8,291
2019-11-14 Mullennix Stephen Chief Operating Officer Sale −608 $26.00 $16K 7,683
2019-11-14 Mullennix Stephen Chief Operating Officer Exercise or conversion · Restricted Stock Units −1,759 8,796
2019-09-04 Schoenberg Mark Chief Medical Officer Exercise or conversion +1,041 6,350
2019-09-04 Schoenberg Mark Chief Medical Officer Sale −343 $33.92 $12K 6,007
2019-09-04 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units (RSUs) −1,041 5,209
2019-08-20 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion +4,167 4,167
2019-08-20 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −1,416 $33.07 $47K 2,751
2019-08-20 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −4,167 8,333
2019-08-15 Mullennix Stephen Chief Operating Officer Sale −608 $31.65 $19K 6,532
2019-08-14 Mullennix Stephen Chief Operating Officer Exercise or conversion +1,759 7,140
2019-08-14 Mullennix Stephen Chief Operating Officer Exercise or conversion · Restricted Stock Units −1,759 10,555

Page 24 of 25 · 496 trades